Q2 2021

Filed Aug 16, 2021 · 10-Q · 47 days after period end · 0001564590-21-044716

Q2 2021 · 10-Q

Revenue—

Net Income

-$1.98M

no prior Q2 2020 on file

EPS Diluted

-$0.15

no prior Q2 2020 on file

Operating Income-$209,718—

Operating Cash Flowderived-$39,053—

Same quarter

no prior Q2 2020 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end

SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR